Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation

Journal of Cellular Physiology

Volumn 206, Issue 3, 2006, Pages 647-654

  Rimondi, Erika ^a   Secchiero, Paola ^a   Quaroni, Andrea ^b   Zerbinati, Carlotta ^c   Capitani, Silvano ^a   Zauli, Giorgio ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CXCL9 CHEMOKINE; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; DEATH RECEPTOR; DEATH RECEPTOR 4; DEATH RECEPTOR 5; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; OSTEOPROTEGERIN; PROTEIN P21; PROTEIN P27; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL IMMORTALIZATION; CELL LINE; CELL STRAIN TSFHI; CHIMERA; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; INTESTINE CRYPT; INTESTINE MUCOSA; INTESTINE VILLUS; JEJUNUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HUMANS; INTESTINES; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 31944445326     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20512     Document Type: Article

References (29)

1. Aliaga JC, Deschenes C, Beaulieu JF, Calvo EL, Rivard N. 1999. Requirement of the MAP kinase cascade for cell cycle progression and differentiation of human intestinal cells. Am J Physiol Gastrointest Liver Physiol 40:631-641.
2. Banner KH, Cattaneo C, Le Net JL, Popovic A, Collins D, Gale JD. 2004. Macroscopic, microscopic, and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene. Or J Pharmacol 143:590-598.
3. Cerda SR, Bissonnette M, Scaglione-Sewell B, Bresitus TA. 2001. PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 120:1700-1712.
4. Franchimont N, Reenaers C, Lambert C, Belaiche J, Bours V, Malaise M, Delvenne P, Louis E. 2004. Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol 138:491-498.
5. Karam SM. 1999. Lineage commitment and maturation of epithelial cells in the gut. Front Biosci 4:286-298.
6. Kim M, Park SY, Pai HS, Kim TH, Billiar TR, Seol DW. 2004. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation. Cancer Res 64:4078-4081.
7. Koornstra JJ, Kleibeuker JH, van Geelen CM, Rijcken FE, Hollema H, de Vries EG, de Jong S. 2003. Expression of TRAIL (TNF-related apoptosis-inducing ligand) and its receptors in normal colonie mucosa, adenomas, and carcinomas. J Pathol 200:327-335.
8. Laprise P, Chailler P, Houde M, Beaulieu JF, Boucher MJ, Rivard N. 2002. Phosphatidylinositol 3-kinase controls human intestinal epithelial cell differentiation by promoting adherents junction assembly and p38 MAPK activation. J Biol Chem 277:8226-8234.
9. Le Blanc HN, Ashkenazi A. 2003. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10:66-75.
10. Mariadason JM, Arango D, Corner GA, Aranes MJ, Hotchkiss KA, Yang W, Augenlicht LH. 2002. A gene expression profile that defines colon cell maturation in vivo. Cancer Res 62:4791-4804.
11. Naka T, Sugamura K, Hylander BL, Widmer MB, Rustum YM, Repasky EA. 2002. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors growth in SCID mice. Cancer Res 62:5800-5806.
12. Pageot LP, Perreault N, Basora N, Francoeur C, Magny P, Beaulieu JF. 2000. Human cell models to study small intestinal functions: Recapitulation of the crypt-villus axis. Microsc Res Tech 49:394-406.
13. Quaroni A, Beaulieu JF. 1997. Cell dynamics and differentiation of conditionally immortalized human intestinal epithelial cells. Gastroenterology 113:1198-1213.
14. Ravi T, Bedi A. 2002. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colonrectal cancers: Synergism with sulindac-mediated inhibition of Bcl-XI. Cancer Res 62:1583-1587.
15. Renshaw SA, Parmar JS, Singleton V, Rowe SJ, Dockrell DH, Dower SK, Bingle CD, Chilvers ER, Whyte MK. 2003. Acceleration of human neutrophil apoptosis by TRAIL. J Immunol 170:1027-1033.
16. Sasaki S, Yoneyama H, Suzuki K, Suriki H, Aiba T, Watanabe S, Kawauchi Y, Kawachi H, Shimizu F, Matsushima K, Asakura H, Narumi S. 2002. Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol 32:3197-3205.
17. Secchiero P, Corallini F, di Iasio MG, Gonelli A, Barbarotto E, Zauli G. 2005. TRAIL counteracts the pro-adhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Blood 105:3413-3419.
18. Shibahara T, Wilcox JN, Couse T, Madara JL. 2001. Characterization of epithelial chemoattractants for human intestinal intraepithelial lymphocytes. Gastroenterology 120:60-70.
19. Singer M, Sansonetti PJ. 2004. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J Immunol 173: 4197-4206.
20. Strater J, Hinz U, Walczak H, Mechtersheimer G, Koretz K, Herfarth C, Moller P, Lehnert T. 2002a. Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res 8:3734-3740.
21. Strater J, Walczak H, Pukrop T, Von Muller L, Hasel C, Kornmann M, Mertens T, Moller P. 2002b. TRAIL and its receptors in the colonic epithelium: A putative role in the defense of viral infections. Gastroenterology 122:659-666.
22. Tang X, Sun YJ, Half E, Kuo T, Sinicrope F. 2002. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to TRAIL-induced apoptosis in human colon cancer cells. Cancer Res 62:4903-4908.
23. Tian JQ, Quaroni A. 1999. Involvement of p21(WAF1/Cip1) and p27(kip1) in intestinal epithelial cell differentiation. Am J Physiol 276:1245-1258.
24. Tillman DM, Izeradjene K, Szucs KS, Douglas L, Houghton JA. 2003. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res 63:5118-5125.
25. Vachon PH, Harnois C, Grenier A, Dufour G, Bouchard V, Han J, Landry J, Beaulieu JF, Vézina A, Dydensborg AB, Gauthier R, Coté A, Drolet JF, Lareau F. 2002. Differential state-selective roles of p38 isoforms in human intestinal epithelial cell anoikis. Gastroenterology 123:1980-1991.
26. Vidal K, Serrant P, Schlosser B, van den Broek P, Lorget F, Donnet-Hughes A. 2004. Osteoprotegerin production by human intestinal epithelial cells: A potential regulator of mucosal immune responses. Am J Physioi Gastrointest Liver Physiol 287:834-836.
27. Wang Q, Wang X, Hernandez A, Kim S, Evers BM. 2001. Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and caco-2 intestinal cell differentiation. Gastroenterology 120:1381-1392.
28. Wang Q, Wang X, Hernandez A, Hellmich MR, Gatalica Z, Evers BM. 2002. Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/ GSK-3 pathway in human colon cancer cells. J Biol Chem 277:36602-36610.
29. Xiang H, Fox JA, Totpal K, Aikawa M, Dupree K, Sinicropi D, Lowe J, Escandon E. 2002. Enhanced tumor killing by Apo2L/TRAIL and CPT-11 co-treatment is associated with p21 cleavage and differential regulation of Apo2L/TRAIL ligand and its receptors. Oncogene 21:3611-3619.